https://www.selleckchem.com/sc....reening/kinase-inhib
49, 83 versus 82% (p=.39 and 83 versus 78% (p=.038) respectively. Among recipients with a high-risk score, donor factors of age ≥60 years, grafts obtained from national sharing and macro-steatosis 15% were associated with 1-year patient survival below 66%. Among ACLF-3 liver transplant recipients, those with high risk at the time of transplant receiving better quality graft will improve post-transplant outcomes. Prospective studies using additional characteristics are needed to derive an accurate risk score mod
Like
Comment
Share
